Glycologix Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Glycologix is a biotechnology research company based in Beverly, Massachusetts. It focuses on locally delivered biopolymers intended to protect soft tissues by replenishing naturally occurring proteoglycans, addressing conditions such as interstitial cystitis, dry eye, post-surgical adhesion prevention, osteoarthritis, spinal disk disease, and wound repair. The company leverages a platform discovery engine to create synthetic structural mimics of proteoglycans that, despite their high molecular weight, remain highly soluble to achieve broad tissue coverage. Glycologix operates in a niche of the biotechnology sector that aims to advance tissue protection and repair through novel biopolymer materials. The firm is a small-scale operation, supported in part by NIH grants, and has announced development of a biopolymer instillate for treating underserved interstitial cystitis/bladder pain syndrome with plans to enter clinical trials in mid-2023.